American Society of Clinical Oncology (ASCO) shared on LinkedIn:
“Updated ASCO Guideline: Breast Cancer Follow-Up and Surveillance After Primary Treatment.
Developed by an Expert Panel using a systematic review and formal consensus process, the update provides guidance on:
- Implementing a risk-based approach to follow-up frequency and intensity.
- Utilizing virtual or in-person visits for routine care.
- Managing closer surveillance for high-risk patients, including those with residual disease following neoadjuvant chemotherapy.
- The role of blood-based biomarkers and supplemental imaging.
Read the full updated guideline to see how these evidence-based updates support individualized care.”
Title: Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update
Authors: Zeina Nahleh, Catherine M. Alfano, Mark R. Somerfield, Janie M. Lee, Tina J. Hieken, Allison Magnuson, Ruta D. Rao, Helen K. Chew, Stephen K.L. Chia, Brittany E. Harvey, Ellen Landsberger, Bora Lim, Sitna Ali Mwanzi, Heather A. Parsons, Debra Patt, Jasmine S. Sukumar, Hyuna Sung, Gustavo Werutsky, Maryam Lustberg
You can also read:
Maryam Lustberg: New ASCO Guideline Introduces Risk-Based Breast Cancer Follow-Up
